ask="N/A"
ask_size="N/A"
average_daily_volume="27606"
bid="N/A"
bid_size="N/A"
book_value="2.04"
change="-0.20"
change_from_200_day_moving_average="-0.78"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-3.04"
change_From_52_week_low="1.76"
change_in_percent="-3.74%"
close="5.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.73"
ebitda="-18.35M"
eps_estimate_current_year="-1.92"
eps_estimate_next_quarter="-0.40"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="2931000"
high="5.40"
high_52_weeks="8.19"
last_trade_date="1/17/2017"
last_trade_price="5.15"
last_trade_size="138"
last_trade_time="3:59pm"
low="5.15"
low_52_weeks="3.39"
market_capitalization="32.16M"
moving_average_200_day="5.93"
moving_average_50_day="5.05"
name="Aldeyra Therapeutics
Inc."
notes="N/A"
one_year_target_price="20.00"
open="5.39"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.21%"
percent_change_from_50_day_moving_average="+1.97%"
percent_change_from_52_week_high="-37.12%"
percent_change_from_52_week_low="+51.92%"
previous_close="5.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.62"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="6245000"
short_ratio="1.82"
stock_exchange="NCM"
symbol="ALDX"
volume="916"
weeks_range_52="3.39 - 8.19"
